| Q4 net sales growth (YoY) | ~9% | CFO |
| Q4 adjusted EBITDA growth (YoY) | 13% | CFO |
| Q4 non-GAAP net income growth (YoY) | 17% | CFO |
| Q4 non-GAAP EPS | $1.02 | CFO |
| Specialty segment net sales growth (YoY) | 9% | CFO |
| Specialty segment gross margin | 10.3% | CFO |
| Specialty segment adjusted EBITDA margin | 3.6% | CFO |
| Intelisys annualized net billings | ~$2.8B | CFO |
| Full year net sales | ~$3.0B | CFO |
| Full year gross profit | $408.6M | CFO |
| Full year adjusted EBITDA | $144.7M | CFO |
| Full year gross margin | 13.4% | CFO |
| Full year adjusted EBITDA margin | 4.76% | CFO |
| Full year recurring revenues % of gross profits | 32.8% | CFO |
| Full year non-GAAP net income | $85.1M | CFO |
| Full year free cash flow | $104M | CFO |
| Full year non-GAAP EPS | $3.57 | CFO |
| Full year share repurchases | $107M | CFO |
| Q4 share repurchases | $25M | CFO |
| Net debt leverage (trailing 12-month) | ~0x | CFO |
| Q4 adjusted ROIC | 14.9% | CFO |
| Full year adjusted ROIC | 13.6% | CFO |
| FY2026 net sales guidance | $3.1B–$3.3B | CFO |
| FY2026 adjusted EBITDA guidance | $150M–$160M | CFO |
| FY2026 free cash flow guidance | at least $80M | CFO |